Zoetis Inc. $ZTS Shares Sold by Logan Capital Management Inc.

Logan Capital Management Inc. lowered its position in shares of Zoetis Inc. (NYSE:ZTS) by 14.8% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 76,867 shares of the company’s stock after selling 13,366 shares during the quarter. Logan Capital Management Inc.’s holdings in Zoetis were worth $11,987,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after purchasing an additional 2,978 shares during the period. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Zoetis by 4.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 68,508 shares of the company’s stock worth $11,183,000 after buying an additional 2,748 shares during the last quarter. KBC Group NV lifted its position in shares of Zoetis by 14.1% in the 1st quarter. KBC Group NV now owns 315,823 shares of the company’s stock worth $52,000,000 after buying an additional 39,007 shares during the last quarter. Hills Bank & Trust Co boosted its holdings in shares of Zoetis by 10.8% in the 1st quarter. Hills Bank & Trust Co now owns 2,585 shares of the company’s stock valued at $426,000 after buying an additional 253 shares during the period. Finally, Avidian Wealth Enterprises LLC grew its position in shares of Zoetis by 6.8% during the 1st quarter. Avidian Wealth Enterprises LLC now owns 3,805 shares of the company’s stock valued at $627,000 after buying an additional 241 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have issued reports on ZTS shares. UBS Group cut their target price on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a report on Monday, October 20th. Leerink Partnrs cut Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a report on Wednesday, October 8th. Argus restated a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Leerink Partners downgraded Zoetis from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Four equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $195.00.

Zoetis Stock Performance

Shares of NYSE ZTS opened at $147.57 on Tuesday. Zoetis Inc. has a 12-month low of $139.34 and a 12-month high of $184.40. The company has a market cap of $65.40 billion, a PE ratio of 25.40, a P/E/G ratio of 2.35 and a beta of 0.90. The stock has a 50 day simple moving average of $148.08 and a 200-day simple moving average of $153.52. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. The firm had revenue of $2.46 billion for the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm’s revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.4%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.